Excessive numbers and increased resorptive functions of osteoclasts not only lead to severe bone destruction in bone cancer such as multiple myeloma patients, but also stimulate tumour growth. My research is focusing on identification of novel epigenetic inhibitors that control osteoclast differentiation and myeloma cell proliferation. A small molecule library of novel epigenetic compounds has been screened in both osteoclast differentiation assay and myeloma (JJN-3) anti-proliferation assay.
- MSc, Biotechnology, Bioprocessing and Business Management, University of Warwick, Coventry, UK 2012
- B.A., Bioengineering, Shanghai Jiao Tong University, Shanghai, China 2008